Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. EPS 2017–2025
Inmune Bio Inc. annual/quarterly eps history and growth rate from 2021 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Inmune Bio Inc. eps for the quarter ending March 31, 2025 was $0.43, a 29.51% decrease year-over-year.
- Inmune Bio Inc. annual eps for 2025 was $1.86, a 11.85% decrease from 2024.
- Inmune Bio Inc. annual eps for 2024 was $2.11, a 26.35% increase from 2023.
- Inmune Bio Inc. annual eps for 2023 was $1.67, a 9.87% increase from 2022.
- Inmune Bio Inc. annual eps for 2022 was $1.52.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Inmune Bio Inc. EPS — FAQ
Inmune Bio Inc. (INMB) eps over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Inmune Bio Inc.'s eps?
Inmune Bio Inc. (INMB) reported eps of $-1.86 for fiscal 2025.
Where can I see INMB's eps history?
The chart and table above show Inmune Bio Inc.'s eps by year and by quarter, including the growth rate.